When the FDA declared pharmacists could prescribe Pfizer's antiviral treatment directly to patients in early July, it caused a flurry of mixed reactions among the healthcare industry. The widespread staffing shortage could be halting the process, though.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,